Search

Selective alkaline and earth alkaline metal ion encapsulation by six different Lehn-type cryptands was predicted by DFT (B3LYP/LANL2DZp) computational chemistry. All cryptands contain three identical moieties connected by the aliphatic nitrogen atom, constructing a very structurally flexible system for accommodating different-sized metal cations. Inspiration for selected hosts was taken from already well-known Lehn-type Cryptand [phen.phen.phen] where one phenanthroline was substituted by 5H-cyclopenta[2,1-b:3,4b′]pyridine in which the CH2– group was replaced by a series of heteroatoms forming the selected series of investigated hosts. The ion selectivity and the ability of the hosts to adjust their structure to accommodate the metal cations successfully were based on energy and geometric criteria. Medium-size cations have been proven to be best fitted for the selected host series. [ABSTRACT FROM AUTHOR]

Purpose: The aim of this study was to contribute to the understanding of the inhibitory effects of bisphosphonates on tissues, with a special focus on angiogenesis. Referring to bisphosphonate-associated osteonecrosis of the jaw (BP-ONJ), it should be shown that the local addition of the isoprenoid geranyl-geraniol (GGOH) prevents vascularization processes. Methods: A mouse model with n = 24 animals which received an injection of a collagen matrix was used. In 4 subgroups (n = 6), we examined the effect of zoledronate on the sprouting of capillary-like structures into the matrix, with and without the presence of geranyl-geraniol, as well as testing against control groups with PBS injections or collagen matrix containing PBS instead of GGOH. This was followed by a histological evaluation of the capillary-like structures. Results: Zoledronate inhibits the sprouting of blood vessels into a collagen matrix in vivo; in the presence of GGOH this effect is significantly weakened by a factor of 3.9 (p = 0.00068). Conclusion: This work commits to the investigation of the pathophysiology of BP-ONJ and shows a possible causal therapeutic path via the topical application of GGOH. [ABSTRACT FROM AUTHOR]